LLY News
Eli Lilly and Company
$1,354.00
-$10.73(-0.79%)
69
Overall
45
Value
91
Tech
71
Quality
Market Cap
$1.27T
Volume
3.81M
52W Range
$850.51 - $1,453.00
Target Price
$1,441.93
LLY news: the latest Eli Lilly and Company headlines, press releases and market updates, newest first.
Latest LLY News
- The Week That Was, The Week Ahead: Macro and Markets, November 8Ran Melamed · Nov 8, 2026
- Hims & Hers Stock Jumps Ahead of Q3 Earnings on Nov. 9 — Here’s WhySolomon Oladipupo · Nov 6, 2026
- Eli Lilly Updates Early Imlunestrant Study as Investors Watch Cancer Pipeline ProgressTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 5, 2026
- Lilly Advances Phase 3 Study of Next-Generation Obesity TreatmentTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 4, 2026
- Morgan Stanley Reaffirms Their Buy Rating on CSL (CMXHF)TipRanks Auto-Generated Intelligence Newsdesk · Nov 4, 2026
- Lilly Updates Early-Stage LY3867070 Study as Investors Await More DataTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 3, 2026
- Analysts Offer Insights on Financial Companies: Brown & Brown (BRO), Ally Financial (ALLY) and TMX Group (OtherTMXXF)TipRanks Newsroom · Nov 2, 2026
- Analysts’ Opinions Are Mixed on These Financial Stocks: Ally Financial (ALLY) and Brown & Brown (BRO)TipRanks Newsroom · Nov 2, 2026
- Eli Lilly & Co (LLY) Receives a Rating Update from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Nov 2, 2026
- RBC Capital Remains a Buy on Eli Lilly & Co (LLY)TipRanks Auto-Generated Intelligence Newsdesk · Oct 30, 2026
- Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), Kymera Therapeutics (KYMR)TipRanks Newsroom · Oct 30, 2026
- Novo Stock (NVO) Falls After Another Head-to-Head Obesity Trial Loss to Eli LillySolomon Oladipupo · Oct 28, 2026
- Eli Lilly’s (LLY) Head of International Business RetiresJoel Baglole · Oct 28, 2026
- Analysts Have Conflicting Sentiments on These Financial Companies: Ally Financial (ALLY) and Brown & Brown (BRO)TipRanks Newsroom · Oct 27, 2026
- Wall Street Has High Expectations for Eli Lilly Stock (LLY) Heading into EarningsJoel Baglole · Oct 26, 2026
- Analysts Conflicted on These Financial Names: Ally Financial (ALLY) and American Express (AXP)TipRanks Newsroom · Oct 26, 2026
- The Week That Was, The Week Ahead: Macro and Markets, October 25Ran Melamed · Oct 25, 2026
- Morgan Stanley Sticks to Its Buy Rating for CSL (CMXHF)TipRanks Auto-Generated Intelligence Newsdesk · Oct 23, 2026
- Macquarie Reaffirms Their Hold Rating on CSL (CMXHF)TipRanks Auto-Generated Intelligence Newsdesk · Oct 22, 2026
- Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF)TipRanks Newsroom · Oct 21, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LLY | $1,354.00 | -0.8% | 3.81M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |